Capmatinib Withdrawn Phase 2 Trials for Advanced Hepatocellular Carcinoma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01964235Study of Efficacy and Safety INC280 in Patients With Advanced Hepatocellular Carcinoma